Indicators of therapeutic effect in FIT-06, a Phase II trial of a DNA vaccine, GTU®-Multi-HIVB, in untreated HIV-1 infected subjects-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Indicators of therapeutic effect in FIT-06, a Phase II trial of a DNA vaccine, GTU®-Multi-HIVB, in untreated HIV-1 infected subjects

Published:2012-06 Issue:27 Volume:30 Page:4046-4054
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Vardas Eftyhia,Stanescu Ioana,Leinonen Mika,Ellefsen Kim,Pantaleo Giuseppe,Valtavaara Minna,Ustav Mart,Reijonen Kalevi

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference33 articles.

1. Immunology and the elusive AIDS vaccine;Virgin;Nature,2010

2. The quest for an HIV-1 therapeutic vaccine;Gandhi;Journal of Infectious Diseases,2005

3. The challenge of finding a cure for HIV infection;Richman;Science,2009

4. Therapeutic immunization for the control of HIV-1: where are we now?;Dorrell;International Journal of STD and AIDS,2006

5. HIV-1 therapeutic vaccines;Kinloch-de;Journal of Infection,2002

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. T Cell Immunogenicity, Gene Expression Profile, and Safety of Four Heterologous Prime-Boost Combinations of HIV Vaccine Candidates in Healthy Volunteers: Results of the Randomized Multi-Arm Phase I/II ANRS VRI01 Trial;The Journal of Immunology;2022-06-15

2. Progress Towards a Therapeutic HIV DNA Vaccine;Expert Review of Vaccines;2022-04-06

3. The HIV Reservoir and Cure and Remission Strategies;Fundamentals of HIV Medicine 2021;2021-06

4. A Randomized Placebo-Controlled Efficacy Study of a Prime Boost Therapeutic Vaccination Strategy in HIV-1-Infected Individuals: VRI02 ANRS 149 LIGHT Phase II Trial;Journal of Virology;2021-04-12

5. In the Era of mRNA Vaccines, Is There Any Hope for HIV Functional Cure?;Viruses;2021-03-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3